6.22 A Double-Blind, Placebo-Controlled, Dose-Ranging Study of Extended-Release Viloxazine (SPN-812 ER) in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)
2017 ◽
Vol 56
(10)
◽
pp. S283-S284
2020 ◽
Vol 30
(2)
◽
pp. 58-68
2012 ◽
Vol 73
(12)
◽
pp. 1517-1523
◽
2006 ◽
Vol 28
(2)
◽
pp. 266-279
◽
2020 ◽
Vol 30
(1)
◽
pp. 2-14
◽
2016 ◽
Vol 55
(10)
◽
pp. S217-S218
◽
2004 ◽
Vol 43
(11)
◽
pp. 1422-1429
◽